Treatment of experimental gram-negative and gram-positive bacterial sepsis with the hematoregulatory peptide SK&F 107647

Journal of Infectious Diseases

Volumn 173, Issue 1, 1996, Pages 203-211

  DeMarsh, Peter L ^a   Wells, Grace I ^a   Lewandowski, Thomas F ^a   Frey, Carrie L ^a   Bhatnagar, Pradip K ^a   Ostovic, Evelyn Judith R ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

5 OXOPROLYL ALPHA GLUTAMYL ALPHA ASPARTYL N8(5 AMINO 1 CARBOXYPENTYL) 8 OXO N7 [N [N (5 OXOPROLYL)ALPHA GLUTAMYL]ALPHA ASPARTYL]THREO 2,7,8 TRIAMINOOCTANOYLLYSINE; ANTIINFECTIVE AGENT; CD11B ANTIGEN; CEFTAZIDIME; ERYTHROMYCIN; GENTAMICIN; GLASPIMOD; PENICILLIN G; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VANCOMYCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBIOTIC SENSITIVITY; ANTIGEN EXPRESSION; ARTICLE; BACTERIAL INFECTION; CONTROLLED STUDY; DOSE RESPONSE; DRUG FORMULATION; DRUG STRUCTURE; DRUG SYNTHESIS; EFFECTOR CELL; ESCHERICHIA COLI; EXPERIMENTAL INFECTION; FIBRIN CLOT; HOST RESISTANCE; MALE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; SEPSIS; STAPHYLOCOCCUS AUREUS; SUBCUTANEOUS DRUG ADMINISTRATION; SURVIVAL;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, ORAL; ANIMALS; ANTI-BACTERIAL AGENTS; ANTIGENS, CD11; BACTEREMIA; DOSE-RESPONSE RELATIONSHIP, DRUG; ESCHERICHIA COLI INFECTIONS; GENTAMICINS; INJECTIONS, SUBCUTANEOUS; LYMPHOCYTES; MALE; OLIGOPEPTIDES; RATS; RATS, INBRED F344; STAPHYLOCOCCAL INFECTIONS; SURVIVAL RATE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030070391     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/173.1.203     Document Type: Article

References (15)

1. Harkema JM, Singh G, Wang P, Chaudry IH. Pharmacologic agents in the treatment of ischemia, hemorrhagic shock, and sepsis. J Crit Care 1992;7:189-216.
2. Roilides E, Pizzo PA. Modulation of host defenses by cytokines: evolving adjuncts in prevention and treatment of serious infections in immunocompromised hosts. Clin Infect Dis 1992;15:508-24.
3. Wichterman KA, Baue AE, Chaudry IH. Sepsis and septic shock - a review of laboratory models and a proposal. J Surg Res 1980;29:189-201.
4. Fink MP, Heard SO. Current research review. Laboratory models of sepsis and septic shock. J Surg Res 1990;49:186-96.
5. Bagby GJ, Plessala KJ, Wilson LA, Thompson JJ, Nelson S. Divergent efficacy of antibody to tumor necrosis factor-α in intravascular and peritonitis models of sepsis. J Infect Dis 1991;163:83-8.
6. Hinshaw LB, Benjamin B, Holmes DD, et al. Responses of the baboon to live Escherichia coli organisms and endotoxin. Surg Gynecol Obstet 1977;145:1-11.
7. Fong Y, Tracey KJ, Moldawer LL, et al. Antibodies to cachectin/tumor necrosis factor reduce interleukin-1β and interleukin-6 appearance during lethal bacteremia. J Exp Med 1989;170:1627-33.
8. Melissen PMB, van Vianen W, Bakker-Woudenberg IAJM. Treatment of Klebsiella pneumoniae septicemia in normal and leukopenic mice by liposome-encapsulated muramyl tripeptide phosphatidylethanolamide. Antimicrob Agents Chemother 1994;38:147-50.
9. Galanos C, Freudenberg MA, Reutter W. Galactosamine-induced sensitization to the lethal effects of endotoxin. Proc Natl Acad Sci USA 1979;76:5939-43.
10. Ahrenholz DH, Simmons RL. Fibrin in peritonitis. I. Beneficial and adverse effects of fibrin in experimental E. coli peritonitis. Surgery 1980;88:41-7.
11. Lee JT, Ahrenholz DH, Nelson RD, Simmons RL. Mechanisms of the adjuvant effect of hemoglobin in experimental peritonitis. V. The significance of the coordinated iron component. Surgery 1979;86:41-8.
12. Natanson C, Danner RL, Elin RJ, et al. Role of endotoxemia in cardiovascular dysfunction and mortality. Escherichia coli and Staphylococcus aureus challenges in a canine model of human septic shock. J Clin Invest 1989;83:243-51.
13. Natanson C, Danner RL, Fink MP, et al. Cardiovascular performance with E. coli challenges in a canine model of human sepsis. Am J Physiol 1988;254:H558-69.
14. Natanson C, Fink MP, Ballantyne HK, MacVittie TJ, Conklin JJ, Parrillo JE. Gram-negative bacteremia produces both severe systolic and diastolic cardiac dysfunction in a canine model that simulates human septic shock. J Clin Invest 1986;78:259-70.
15. Pelus LM, Bhatnagar P, Frey C, DeMarsh P, King A. Stimulation of murine myelopoiesis in vitro and in vivo by the synthetic peptide SK& F 107647 [abstract]. Exp Hematol 1991;19:487.